Ordering Recommendation
Mnemonic
OSTEO NMID
Methodology
Quantitative Electrochemiluminescent Immunoassay
Performed
Tue-Sat
Reported
1-4 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
Collect
Serum separator tube. Also acceptable: Lavender (EDTA), pink (K2EDTA), or green (sodium or lithium heparin).
Specimen Preparation
Allow serum tube to sit for 15-20 minutes at room temperature for proper clot formation. Centrifuge and separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 0.5 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.3 mL)
Storage/Transport Temperature
Frozen.
Unacceptable Conditions
Hemolyzed specimens.
Remarks
Stability
After separation from cells: Ambient: 8 hours; Refrigerated: 72 hours; Frozen: 3 months
Reference Interval
Age |
Male |
Female |
---|---|---|
6 months-6 years | 39-121 ng/mL | 44-130 ng/mL |
7-9 years | 66-182 ng/mL | 73-206 ng/mL |
10-12 years | 85-232 ng/mL | 77-262 ng/mL |
13-15 years | 70-336 ng/mL | 33-222 ng/mL |
16-17 years | 43-237 ng/mL | 24-99 ng/mL |
18 years and older | 11-50 ng/mL | 11-50 ng/mL |
Interpretive Data
In patients with renal failure the osteocalcin result can be elevated, both directly, due to impaired clearance, and indirectly, due to renal osteodystrophy.
Compliance Category
FDA
Note
Hotline History
N/A
CPT Codes
83937
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
0020728 | Osteocalcin by ECIA | 2697-1 |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
- BGLAP
- bone gamma-carboxyglutamic acid-containing protein
- N-MID osteocalcin
- Osteocalcin
- Osteocalcin (OCN)
Osteocalcin by Electrochemiluminescent Immunoassay